Prospective data on correlation between dermoscopic features of vitiligo and disease activity
are scarce. This study was conducted to sequentially determine the dermoscopic features of …

Abstract Background Narrowband ultraviolet B (NB‐UVB) phototherapy promotes stability
and repigmentation in vitiligo. No studies have compared targeted NB‐UVB with whole …

Vitiligo is an acquired depigmentation skin disease caused by immune-mediated death of
melanocytes. The most common treatment for vitiligo is narrow band ultraviolet B …

Objectives Dyschromia is an understudied aspect of hypertrophic scar (HTS). The use of
topical tacrolimus has successfully shown repigmentation in vitiligo patients through …

Background The search for objective factors that help in predicting the response of vitiligo
treatment is very important. Objective We sought to evaluate the effect of NB-UVB …

Inflammatory skin disorders can produce localized areas of cutaneous lentiginosis,
particularly as the inflammation retreats in response to treatment. This post-inflammatory …

Although perifollicular repigmentation in the vitiligo lesions is owing to activation of follicular
melanocyte stem cells and/or precursor cells followed by supplying matured melanocytes …

MATERIALS AND METHODS Vitiligo is an acquired depigmentation skin disorder that
affects 0.5%–2% of world's population (1). Patients with vitiligo develop white patches on …

Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of
110 patients. Clear improvement after 21 NB-UVB phototherapy sessions and concomitant …

This invention provides the use of specialized proresolving mediators (SPMs) for use as
melanocyte growth promoters and pro-survival factors. More particularly, the SPM …